1. Home
  2. MDT vs DHR Comparison

MDT vs DHR Comparison

Compare MDT & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDT
  • DHR
  • Stock Information
  • Founded
  • MDT 1949
  • DHR 1969
  • Country
  • MDT Ireland
  • DHR United States
  • Employees
  • MDT N/A
  • DHR N/A
  • Industry
  • MDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DHR Industrial Machinery/Components
  • Sector
  • MDT Health Care
  • DHR Industrials
  • Exchange
  • MDT Nasdaq
  • DHR Nasdaq
  • Market Cap
  • MDT 114.9B
  • DHR 135.4B
  • IPO Year
  • MDT N/A
  • DHR N/A
  • Fundamental
  • Price
  • MDT $98.29
  • DHR $208.67
  • Analyst Decision
  • MDT Buy
  • DHR Strong Buy
  • Analyst Count
  • MDT 15
  • DHR 18
  • Target Price
  • MDT $103.46
  • DHR $257.29
  • AVG Volume (30 Days)
  • MDT 7.8M
  • DHR 5.1M
  • Earning Date
  • MDT 11-18-2025
  • DHR 10-21-2025
  • Dividend Yield
  • MDT 2.89%
  • DHR 0.61%
  • EPS Growth
  • MDT 21.95
  • DHR N/A
  • EPS
  • MDT 3.62
  • DHR 4.71
  • Revenue
  • MDT $34,200,000,000.00
  • DHR $24,013,000,000.00
  • Revenue This Year
  • MDT $7.98
  • DHR $4.46
  • Revenue Next Year
  • MDT $5.46
  • DHR $5.93
  • P/E Ratio
  • MDT $27.16
  • DHR $44.30
  • Revenue Growth
  • MDT 4.98
  • DHR 1.89
  • 52 Week Low
  • MDT $79.29
  • DHR $171.00
  • 52 Week High
  • MDT $99.32
  • DHR $279.41
  • Technical
  • Relative Strength Index (RSI)
  • MDT 67.74
  • DHR 60.01
  • Support Level
  • MDT $91.87
  • DHR $180.03
  • Resistance Level
  • MDT $95.99
  • DHR $219.92
  • Average True Range (ATR)
  • MDT 1.78
  • DHR 5.65
  • MACD
  • MDT 0.30
  • DHR 2.99
  • Stochastic Oscillator
  • MDT 84.08
  • DHR 74.00

About MDT Medtronic plc.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

About DHR Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

Share on Social Networks: